ID   APOC1_HUMAN             Reviewed;          83 AA.
AC   P02654; B2R526; Q6IB97;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-1986, sequence version 1.
DT   15-MAR-2017, entry version 169.
DE   RecName: Full=Apolipoprotein C-I;
DE            Short=Apo-CI;
DE            Short=ApoC-I;
DE   AltName: Full=Apolipoprotein C1;
DE   Contains:
DE     RecName: Full=Truncated apolipoprotein C-I;
DE   Flags: Precursor;
GN   Name=APOC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=6328444; DOI=10.1093/nar/12.9.3909;
RA   Knott T.J., Robertson M.E., Priestley L.M., Urdea M., Wallis S.C.,
RA   Scott J.;
RT   "Characterisation of mRNAs encoding the precursor for human
RT   apolipoprotein CI.";
RL   Nucleic Acids Res. 12:3909-3915(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=2835369;
RA   Lauer S.J., Walker D., Elshourbagy N.A., Reardon C.A., Levy-Wilson B.,
RA   Taylor J.M.;
RT   "Two copies of the human apolipoprotein C-I gene are linked closely to
RT   the apolipoprotein E gene.";
RL   J. Biol. Chem. 263:7277-7286(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10520737; DOI=10.3109/10425179809086433;
RA   Freitas E.M., Zhang W.J., Lalonde J.P., Tay G.K., Gaudieri S.,
RA   Ashworth L.K., Van Bockxmeer F.M., Dawkins R.L.;
RT   "Sequencing of 42kb of the APO E-C2 gene cluster reveals a new gene:
RT   PEREC1.";
RL   DNA Seq. 9:89-100(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Nickerson D.A., Smith J.D., Fullerton S.M., Clark A.G., Stengard J.H.,
RA   Salomaa V., Boerwinkle E., Sing C.F., Weiss K.M.;
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Bechtel S., Schupp I., Duda A., Wellenreuther R., Mehrle A.,
RA   Ruschke V., Poustka A., Wiemann S.;
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 15-83.
RX   PubMed=2985493; DOI=10.1007/BF00291654;
RA   Tata F., Henry I., Markham A.F., Wallis S.C., Weil D., Grzeschik K.H.,
RA   Junien C., Williamson R., Humphries S.E.;
RT   "Isolation and characterisation of a cDNA clone for human
RT   apolipoprotein CI and assignment of the gene to chromosome 19.";
RL   Hum. Genet. 69:345-349(1985).
RN   [13]
RP   PROTEIN SEQUENCE OF 27-83.
RX   PubMed=166984;
RA   Shulman R.S., Herbert P.N., Wehrly K., Fredrickson D.S.;
RT   "The complete amino acid sequence of C-I (apoLp-Ser), an
RT   apolipoprotein from human very low density lipoproteins.";
RL   J. Biol. Chem. 250:182-190(1975).
RN   [14]
RP   PROTEIN SEQUENCE OF 27-83.
RX   PubMed=4369340;
RA   Jackson R.L., Sparrow J.T., Baker H.N., Morrisett J.D., Taunton O.D.,
RA   Gotto A.M. Jr.;
RT   "The primary structure of apolipoprotein-serine.";
RL   J. Biol. Chem. 249:5308-5313(1974).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-19.
RX   PubMed=2897845; DOI=10.1016/S0006-291X(88)80424-8;
RA   Smit M.V.D., Kooij-Meijs E., Woudt L.P., Havekes L.M., Frants R.R.;
RT   "Exact localization of the familial dysbetalipoproteinemia associated
RT   HpaI restriction site in the promoter region of the APOC1 gene.";
RL   Biochem. Biophys. Res. Commun. 152:1282-1288(1988).
RN   [16]
RP   FUNCTION.
RX   PubMed=17339654; DOI=10.1194/jlr.M700024-JLR200;
RA   Westerterp M., Berbee J.F., Delsing D.J., Jong M.C., Gijbels M.J.,
RA   Dahlmans V.E., Offerman E.H., Romijn J.A., Havekes L.M., Rensen P.C.;
RT   "Apolipoprotein C-I binds free fatty acids and reduces their
RT   intracellular esterification.";
RL   J. Lipid Res. 48:1353-1361(2007).
RN   [17]
RP   GENE DUPLICATION.
RX   PubMed=25160599; DOI=10.1016/j.cbd.2014.08.001;
RA   Puppione D.L.;
RT   "Higher primates, but not New World monkeys, have a duplicate set of
RT   enhancers flanking their apoC-I genes.";
RL   Comp. Biochem. Physiol. 11:45-48(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   STRUCTURE BY NMR OF 33-50 AND 61-79.
RX   PubMed=7779782; DOI=10.1021/bi00022a013;
RA   Rozek A., Buchko G.W., Cushley R.J.;
RT   "Conformation of two peptides corresponding to human apolipoprotein C-
RT   I residues 7-24 and 35-53 in the presence of sodium dodecyl sulfate by
RT   CD and NMR spectroscopy.";
RL   Biochemistry 34:7401-7408(1995).
RN   [20]
RP   STRUCTURE BY NMR OF 27-64.
RX   PubMed=9300485; DOI=10.1002/pro.5560060906;
RA   Rozek A., Buchko G.W., Kanda P., Cushley R.J.;
RT   "Conformational studies of the N-terminal lipid-associating domain of
RT   human apolipoprotein C-I by CD and 1H NMR spectroscopy.";
RL   Protein Sci. 6:1858-1868(1997).
RN   [21]
RP   STRUCTURE BY NMR OF 27-83.
RX   PubMed=10545169; DOI=10.1021/bi982966h;
RA   Rozek A., Sparrow J.T., Weisgraber K.H., Cushley R.J.;
RT   "Conformation of human apolipoprotein C-I in a lipid-mimetic
RT   environment determined by CD and NMR spectroscopy.";
RL   Biochemistry 38:14475-14484(1999).
RN   [22]
RP   VARIANT MET-16.
RX   PubMed=10391210; DOI=10.1038/10297;
RA   Halushka M.K., Fan J.-B., Bentley K., Hsie L., Shen N., Weder A.,
RA   Cooper R., Lipshutz R., Chakravarti A.;
RT   "Patterns of single-nucleotide polymorphisms in candidate genes for
RT   blood-pressure homeostasis.";
RL   Nat. Genet. 22:239-247(1999).
RN   [23]
RP   VARIANT SER-71, AND CHARACTERIZATION OF VARIANT SER-71.
RX   PubMed=16981907; DOI=10.1111/j.1742-4658.2006.05473.x;
RA   Wroblewski M.S., Wilson-Grady J.T., Martinez M.B., Kasthuri R.S.,
RA   McMillan K.R., Flood-Urdangarin C., Nelsestuen G.L.;
RT   "A functional polymorphism of apolipoprotein C1 detected by mass
RT   spectrometry.";
RL   FEBS J. 273:4707-4715(2006).
CC   -!- FUNCTION: Inhibitor of lipoprotein binding to the low density
CC       lipoprotein (LDL) receptor, LDL receptor-related protein, and very
CC       low density lipoprotein (VLDL) receptor. Associates with high
CC       density lipoproteins (HDL) and the triacylglycerol-rich
CC       lipoproteins in the plasma and makes up about 10% of the protein
CC       of the VLDL and 2% of that of HDL. Appears to interfere directly
CC       with fatty acid uptake and is also the major plasma inhibitor of
CC       cholesteryl ester transfer protein (CETP). Binds free fatty acids
CC       and reduces their intracellular esterification. Modulates the
CC       interaction of APOE with beta-migrating VLDL and inhibits binding
CC       of beta-VLDL to the LDL receptor-related protein.
CC       {ECO:0000269|PubMed:17339654, ECO:0000303|PubMed:25160599}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000303|PubMed:2835369}.
CC   -!- TISSUE SPECIFICITY: Synthesized mainly in liver and to a minor
CC       degree in intestine. Also found in the lung and spleen.
CC       {ECO:0000269|PubMed:2835369}.
CC   -!- MISCELLANEOUS: Apolipoprotein C-I is present in acidic (APOC1A)
CC       and basic (APOC1B) forms in P.paniscus, P.abelii and P.troglodytes
CC       and perhaps also in baboons and macaques. The two genes for ApoC-I
CC       arose through a duplication process that occurred after the
CC       divergence of New World monkeys from the human lineage. In human,
CC       the acidic form has become a pseudogene sometime between the
CC       divergence of bonobos and chimpanzees from the human lineage and
CC       the appearance of the Denisovans. Pseudogenization resulted when
CC       the codon for the penultimate amino acid in the signal sequence
CC       was changed to a stop codon. {ECO:0000303|PubMed:25160599}.
CC   -!- SIMILARITY: Belongs to the apolipoprotein C1 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Apolipoprotein C1 entry;
CC       URL="https://en.wikipedia.org/wiki/Apolipoprotein_C1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00570; CAA25235.1; -; mRNA.
DR   EMBL; M20843; AAA51763.1; -; Genomic_DNA.
DR   EMBL; AF050154; AAD02506.1; -; Genomic_DNA.
DR   EMBL; AY422954; AAQ91813.1; -; Genomic_DNA.
DR   EMBL; BT007142; AAP35806.1; -; mRNA.
DR   EMBL; AK312036; BAG34973.1; -; mRNA.
DR   EMBL; CR456907; CAG33188.1; -; mRNA.
DR   EMBL; AM392727; CAL37605.1; -; mRNA.
DR   EMBL; FJ525874; ACN81312.1; -; Genomic_DNA.
DR   EMBL; CH471126; EAW57307.1; -; Genomic_DNA.
DR   EMBL; BC009698; AAH09698.1; -; mRNA.
DR   EMBL; BC055093; AAH55093.1; -; mRNA.
DR   EMBL; M20902; AAA88018.1; -; Genomic_DNA.
DR   EMBL; M27359; AAA51762.1; -; mRNA.
DR   CCDS; CCDS12648.1; -.
DR   PIR; A28057; LPHUC1.
DR   RefSeq; NP_001307994.1; NM_001321065.1.
DR   RefSeq; NP_001307995.1; NM_001321066.1.
DR   RefSeq; NP_001636.1; NM_001645.4.
DR   UniGene; Hs.110675; -.
DR   UniGene; Hs.737668; -.
DR   PDB; 1ALE; NMR; -; A=33-50.
DR   PDB; 1ALF; NMR; -; A=61-79.
DR   PDB; 1IOJ; NMR; -; A=27-83.
DR   PDB; 1OPP; NMR; -; A=27-64.
DR   PDBsum; 1ALE; -.
DR   PDBsum; 1ALF; -.
DR   PDBsum; 1IOJ; -.
DR   PDBsum; 1OPP; -.
DR   ProteinModelPortal; P02654; -.
DR   SMR; P02654; -.
DR   BioGrid; 106838; 4.
DR   IntAct; P02654; 9.
DR   MINT; MINT-3004014; -.
DR   STRING; 9606.ENSP00000252491; -.
DR   PhosphoSitePlus; P02654; -.
DR   BioMuta; APOC1; -.
DR   DMDM; 114016; -.
DR   EPD; P02654; -.
DR   MaxQB; P02654; -.
DR   PaxDb; P02654; -.
DR   PeptideAtlas; P02654; -.
DR   PRIDE; P02654; -.
DR   TopDownProteomics; P02654; -.
DR   DNASU; 341; -.
DR   Ensembl; ENST00000588750; ENSP00000465356; ENSG00000130208.
DR   Ensembl; ENST00000588802; ENSP00000468029; ENSG00000130208.
DR   GeneID; 341; -.
DR   KEGG; hsa:341; -.
DR   UCSC; uc002pac.2; human.
DR   CTD; 341; -.
DR   DisGeNET; 341; -.
DR   GeneCards; APOC1; -.
DR   HGNC; HGNC:607; APOC1.
DR   HPA; HPA051518; -.
DR   MIM; 107710; gene.
DR   neXtProt; NX_P02654; -.
DR   OpenTargets; ENSG00000130208; -.
DR   PharmGKB; PA51; -.
DR   eggNOG; ENOG410J7EM; Eukaryota.
DR   eggNOG; ENOG410ZDUT; LUCA.
DR   GeneTree; ENSGT00390000011584; -.
DR   HOGENOM; HOG000034001; -.
DR   HOVERGEN; HBG050547; -.
DR   InParanoid; P02654; -.
DR   PhylomeDB; P02654; -.
DR   Reactome; R-HSA-8855121; VLDL interactions.
DR   Reactome; R-HSA-8866423; VLDL biosynthesis.
DR   ChiTaRS; APOC1; human.
DR   EvolutionaryTrace; P02654; -.
DR   GeneWiki; Apolipoprotein_C1; -.
DR   GenomeRNAi; 341; -.
DR   PRO; PR:P02654; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000130208; -.
DR   CleanEx; HS_APOC1; -.
DR   ExpressionAtlas; P02654; baseline and differential.
DR   Genevisible; P02654; HS.
DR   GO; GO:0042627; C:chylomicron; TAS:BHF-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:LIFEdb.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0034364; C:high-density lipoprotein particle; IDA:BHF-UCL.
DR   GO; GO:0034361; C:very-low-density lipoprotein particle; IDA:BHF-UCL.
DR   GO; GO:0005504; F:fatty acid binding; IDA:BHF-UCL.
DR   GO; GO:0055102; F:lipase inhibitor activity; IDA:BHF-UCL.
DR   GO; GO:0031210; F:phosphatidylcholine binding; TAS:BHF-UCL.
DR   GO; GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; TAS:BHF-UCL.
DR   GO; GO:0004859; F:phospholipase inhibitor activity; IDA:BHF-UCL.
DR   GO; GO:0033344; P:cholesterol efflux; IDA:BHF-UCL.
DR   GO; GO:0008203; P:cholesterol metabolic process; IEA:Ensembl.
DR   GO; GO:0034382; P:chylomicron remnant clearance; IDA:BHF-UCL.
DR   GO; GO:0034375; P:high-density lipoprotein particle remodeling; TAS:BHF-UCL.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0042157; P:lipoprotein metabolic process; TAS:Reactome.
DR   GO; GO:0032375; P:negative regulation of cholesterol transport; IDA:BHF-UCL.
DR   GO; GO:0045717; P:negative regulation of fatty acid biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0050995; P:negative regulation of lipid catabolic process; IDA:BHF-UCL.
DR   GO; GO:0045833; P:negative regulation of lipid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0051005; P:negative regulation of lipoprotein lipase activity; IDA:BHF-UCL.
DR   GO; GO:0010900; P:negative regulation of phosphatidylcholine catabolic process; IDA:BHF-UCL.
DR   GO; GO:0048261; P:negative regulation of receptor-mediated endocytosis; IDA:BHF-UCL.
DR   GO; GO:0010916; P:negative regulation of very-low-density lipoprotein particle clearance; IDA:BHF-UCL.
DR   GO; GO:0033700; P:phospholipid efflux; IDA:BHF-UCL.
DR   GO; GO:0034369; P:plasma lipoprotein particle remodeling; IDA:BHF-UCL.
DR   GO; GO:0010873; P:positive regulation of cholesterol esterification; TAS:BHF-UCL.
DR   GO; GO:0032374; P:regulation of cholesterol transport; IC:BHF-UCL.
DR   GO; GO:0006641; P:triglyceride metabolic process; IEA:Ensembl.
DR   GO; GO:0034379; P:very-low-density lipoprotein particle assembly; TAS:BHF-UCL.
DR   GO; GO:0034447; P:very-low-density lipoprotein particle clearance; IGI:BHF-UCL.
DR   InterPro; IPR006781; ApoC-I.
DR   PANTHER; PTHR16565; PTHR16565; 1.
DR   Pfam; PF04691; ApoC-I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Lipid transport; Polymorphism; Reference proteome; Secreted; Signal;
KW   Transport; VLDL.
FT   SIGNAL        1     26       {ECO:0000269|PubMed:166984,
FT                                ECO:0000269|PubMed:4369340}.
FT   CHAIN        27     83       Apolipoprotein C-I.
FT                                /FTId=PRO_0000002014.
FT   CHAIN        29     83       Truncated apolipoprotein C-I.
FT                                {ECO:0000250|UniProtKB:P86336}.
FT                                /FTId=PRO_0000391843.
FT   VARIANT      16     16       I -> M (in dbSNP:rs5112).
FT                                {ECO:0000269|PubMed:10391210}.
FT                                /FTId=VAR_014183.
FT   VARIANT      71     71       T -> S (polymorphism found only in
FT                                persons of American Indian or Mexican
FT                                ancestry; more susceptible to N-terminal
FT                                truncation and shows greater distribution
FT                                to the VLDL than the protein with T-71;
FT                                dbSNP:rs142372275).
FT                                {ECO:0000269|PubMed:16981907}.
FT                                /FTId=VAR_029011.
FT   STRAND       31     33       {ECO:0000244|PDB:1IOJ}.
FT   HELIX        35     48       {ECO:0000244|PDB:1ALE}.
FT   TURN         52     54       {ECO:0000244|PDB:1IOJ}.
FT   STRAND       56     62       {ECO:0000244|PDB:1IOJ}.
FT   HELIX        65     78       {ECO:0000244|PDB:1ALF}.
FT   STRAND       79     81       {ECO:0000244|PDB:1IOJ}.
SQ   SEQUENCE   83 AA;  9332 MW;  4A3614626624AE6A CRC64;
     MRLFLSLPVL VVVLSIVLEG PAPAQGTPDV SSALDKLKEF GNTLEDKARE LISRIKQSEL
     SAKMREWFSE TFQKVKEKLK IDS
//
